ADHD is one of the most prevalent neuropsychiatric illnesses and the second most frequent chronic childhood condition, affecting millions of children and teens in the United States. Considering the growing incidence of ADHD diagnoses in primary care, physicians must have the knowledge and skills to accurately identify and manage this illness in children (Wolraich et al., 2019). APNs who provide care to children and adolescents with ADHD are ideally positioned to uncover evidence-based practices for testing, diagnosing, and treating patients for a quick recovery. This study aims to investigate the function of APNs in diagnosing and treating ADHD in children and adolescents aged 4 to 18 years old in an outpatient clinic using evidence-based practice standards. The Phenomenon of Interest (POI) Significance ADHD is a chronic neurobehavioral condition characterized by inattention, hyperactivity, and impulsivity. It is more common and intense than in people of similar milestone stages; it is one of the most prevalent childhood disorders (Miner et al., 2020). The incidence of ADHD varies depending on diagnostic criteria, examination methodologies, and demographics, with current estimates ranging from 2 percent to 9.5 percent among school-aged children and adolescents (Krull, 2020). The impact of these worries can last a long time, and most people have noticeable symptoms well into adulthood (Wolraich et al., 2019). There are pharmacologic and nonpharmacologic therapies for ADHD can be used alone or in combination (Wolraich et al., 2019). Stimulant and non-stimulant drugs are used as
Order this paper